98 related articles for article (PubMed ID: 317079)
21. [Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].
Mouton C; Dextraze L; Mayrand D
J Biol Buccale; 1984 Mar; 12(1):17-26. PubMed ID: 6584423
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
Abeck D; Johnson AP; Dangor Y; Ballard RC
J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
[TBL] [Abstract][Full Text] [Related]
23. Antibiotics of choice against Bacteroides fragilis.
Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
[No Abstract] [Full Text] [Related]
24. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
[TBL] [Abstract][Full Text] [Related]
25. Common beta-lactamase-specifying plasmid in Haemophilus ducreyi and Neisseria gonorrhoeae.
Anderson B; Albritton WL; Biddle J; Johnson SR
Antimicrob Agents Chemother; 1984 Feb; 25(2):296-7. PubMed ID: 6424563
[TBL] [Abstract][Full Text] [Related]
26. [Josamycin: antibacterial activity against anaerobes (author's transl)].
Watanabe K; Watanabe I; Ezaki T; Kobata S; Imamura H; Ninomiya K; Ueno K; Suzuki S
Jpn J Antibiot; 1978 Aug; 31(8):487-92. PubMed ID: 702806
[No Abstract] [Full Text] [Related]
27. Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis.
Fuchs PC; Thornsberry C; Barry AL; Jones RN; Gavan TL; Gerlach EH; Sommers HM
J Antibiot (Tokyo); 1979 Sep; 32(9):920-7. PubMed ID: 41833
[No Abstract] [Full Text] [Related]
28. Inhibitory and lethal activities of rosaramicin, erythromycin, and clindamycin against Campylobacter fetus subsp jejuni and intestinalis.
Smith JA; Isaac-Renton JL; Jellett JF; Chow AW; Ngui-Yen J
Am J Vet Res; 1983 Aug; 44(8):1605-6. PubMed ID: 6625312
[TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi.
Brunton J; Meier M; Ehrman N; Maclean I; Slaney L; Albritton WL
Antimicrob Agents Chemother; 1982 Jun; 21(6):857-63. PubMed ID: 6287927
[TBL] [Abstract][Full Text] [Related]
30. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
[TBL] [Abstract][Full Text] [Related]
32. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
[TBL] [Abstract][Full Text] [Related]
33. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
Wall RA; Mabey DC; Bello CS; Felmingham D
J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
[TBL] [Abstract][Full Text] [Related]
34. Haemophilus ducreyi is resistant to human antimicrobial peptides.
Mount KL; Townsend CA; Bauer ME
Antimicrob Agents Chemother; 2007 Sep; 51(9):3391-3. PubMed ID: 17620373
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of a beta-lactamase from Haemophilus ducreyi in Escherichia coli.
Lawung R; Prachayasittikul V; Bülow L
Protein Expr Purif; 2001 Oct; 23(1):151-8. PubMed ID: 11570857
[TBL] [Abstract][Full Text] [Related]
37. Effects of subminimal inhibitory concentrations of Erythromycin, Clindamycin, and Pristinamycin on the penicillinase production of Staphlyococcus aureus.
Michel J; Stessman P; Stessman J
Antimicrob Agents Chemother; 1980 Jan; 17(1):13-5. PubMed ID: 6965441
[TBL] [Abstract][Full Text] [Related]
38. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
Davey PG; Jacobus NV; Tally FP
J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
[TBL] [Abstract][Full Text] [Related]
40. Episome profiles and mobilizable beta-lactamase plasmid in Haemophilus ducreyi.
Prachayasittikul V; Lawung R; Bulow L
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):80-4. PubMed ID: 11023070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
